Results for “”

Entry Author Date Location
Vertex Stops Test of Rare Disease Drug, Dimming Pipeline Prospects 10/15/20 Boston
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin 10/14/20 Boston
Roche Enlists Dyno to Bring AI to Next-Generation Liver, CNS Gene Therapies 10/14/20 Boston
SQZ Biotech Lines Up an IPO on the NYSE to Fund Cell Therapy R&D 10/12/20 Boston
FDA Panel Vote Weighs in Favor of Alkermes Psych Drug, With Caveats 10/09/20 Europe
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More 10/09/20 National
Biogen’s AdComm Meeting Will Test FDA’s “Substantial Evidence” Flexibility 10/08/20 Boston
In RNAi Move, Takeda Fronts $300M to Team Up on Arrowhead Liver Drug 10/08/20 National
BIO Launches ‘Biotech Votes’ Campaign to Encourage Registration and Informed Voting 10/08/20 Boston
Scribe Therapeutics Sets Out to Write CRISPR Gene Editing’s Next Chapter 10/06/20 San Francisco
Federation Bio Bags $50M to Engineer New Approach to Microbiome Drugs 10/06/20 Boston
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More 10/02/20 National
FDA Lifts Solid Bio Clinical Hold, Duchenne Study Cleared to Resume 10/01/20 Boston
Pfizer Pumps $200M Into CStone for Rights to PD-L1 Cancer Drug in China 09/30/20 New York
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs 09/28/20 Boston
Galecto Picks Up $64M as Plans for Fibrosis Clinical Trials Move Forward 09/25/20 Europe
Bio Roundup: Grail Acquisition, Libra’s Launch, Tau Trial Results & More 09/25/20 National
Monte Rosa Raises $96M for “Glue-Based” Protein Degrading Drugs 09/24/20 Boston
Libra Strikes a Balance With Approach to ALS and Other Neuro Disorders 09/23/20 San Diego
Athira CEO Kawas: Alzheimer’s Drug Aims for “Recovery of Brain Function” 09/23/20 Seattle
Xconomy Awards On-Demand ‘Meet the Finalists’ Webcast Series Continues This Week 09/21/20 Boston
Illumina to Acquire Cancer Diagnostics Developer Grail in $8B Deal 09/21/20 San Francisco
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More 09/18/20 National
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D 09/17/20 Boston
BIO Chief: “Reckless” Executive Order on Drug Prices Threatens Innovation 09/17/20 Boston
Finch Therapeutics Fetches $90M to Advance Microbiome Drug Pipeline 09/17/20 Boston
Arrowhead Pharma Shares Soar on Early Liver Data for RNAi Drug 09/16/20 Wisconsin
Moderna CMO Talks COVID-19 Vaccine at the Xcelerate Keynote Series 09/16/20 Boston
Neogene Therapeutics Grabs $110M to Tackle Solid Tumors With Cell Therapy 09/15/20 Europe
Join Xconomy Next Week at the Virtual Xcelerate Keynote Series at Biotech Week Boston 09/14/20 Boston
Page 1 of 385 next page »